SCHEMBL4112964

SCHEMBL4112964

C=CC(CC(CC(N)=O)CC(N)=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1712977 0.82 TSHR (0.35)
SCHEMBL19650483 0.74 SLC7A5 (0.38)
SCHEMBL1712976 0.71 BLM (0.35)
SCHEMBL24513224 0.71 BLM (0.35)
SCHEMBL2679188 0.71 TSHR (0.40)
SCHEMBL21167276 0.71 GRIK1 (0.50)
SCHEMBL24340602 0.70 BLM (0.41)
SCHEMBL18850260 0.69
SCHEMBL459915 0.69
SCHEMBL10771743 0.69 GRIK1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090226392-A1 Phosphate-Binding Polymers for Oral Administration GELTEX, INC. 2009-09-10 US disclosed
US-7459151-B2 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2008-12-02 US disclosed
US-20060171916-A1 Phosphate-binding polymers for oral administration HOLMES-FARLEY STEPHEN R 2006-08-03 US disclosed
US-7014846-B2 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2006-03-21 US disclosed
US-6858203-B2 Method of making phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2005-02-22 US disclosed
US-20040191212-A1 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2004-09-30 US disclosed
US-20030133902-A1 Method of making phosphate-binding polymers for oral administration GELTEX PHARMACEUTICALS, INC. 2003-07-17 US disclosed
US-6509013-B1 Water insoluble crosslinked allyl amine homo- or copolymer and carrier; removing phosphate from gastrointestinal tract; hyperphosphatemia GELTEX PHARMACEUTICALS, INC. 2003-01-21 US disclosed
US-5667775-A TREATMENT OF HYPERPHOSPHATEMIA, ION EXCHANGING, CATIONIC POLYMERS, REMOVAL OF PHOSPHATE FROM GASTROINTESTINAL TRACT GELTEX PHARMACEUTICALS, INC. (US) 1997-09-16 US disclosed